The International Journal of Bioprinting (IJB) has reached a significant new milestone in its development. According to the 2025 CiteScore metrics officially released by Elsevier, the journal has achieved a CiteScore of 7.8, rising from 7.3 in 2024 — a notable increase of approximately 6.8%.

This outstanding performance places IJB at 73rd among 425 journals in the Engineering (Industrial and Manufacturing Engineering) category, ranking it within the top 18% of journals in the field. This substantial rise reflects the journal's increasing recognition and influence across the global bioprinting and engineering science research communities.

As an international journal covering the technology, science, and clinical applications of the broadly defined field of bioprinting — defined as the use of 3D printing technology with materials that incorporate viable living cells or biological elements to produce tissue or biotechnological products — IJB is committed to advancing research across all stages of the bioprinting process, from concept creation to fabrication and beyond.

This achievement highlights the collective efforts of the journal's editorial team, reviewers, authors, and readers, as well as IJB's ongoing commitment to publishing high-quality original research, brief commentaries, and reviews that span basic and applied research, including the practical applications of 3D-printed products and their associated social implications.

Looking ahead, IJB will continue to uphold the trust and expectations of the research community. Guided by rigorous peer review and a dedication to scientific integrity, the journal remains committed to serving as a premier international platform for disseminating knowledge generated in bioprinting-related research.

IJB extends its sincere gratitude to all editors, reviewers, authors, and readers for their continued support and contributions to the journal's success.